Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Open-market buy Director bought 500,000 shares at an average $4.53 ($2,265,390)
  2. 4 Open-market buy Director bought 250,000 shares at an average $4.39 ($1,097,440)
  3. 4 Open-market buy President and CEO bought 20,000 shares at $4.12 ($82,374)
  4. 4 Open-market buy Director bought 200,000 shares at $4.00 ($799,160)
  5. 4 Open-market buy President and CEO bought 10,000 shares at $4.06 ($40,550)
  6. 4 Open-market buy President and CEO bought 10,000 shares at $4.04 ($40,390)
  7. 4 Open-market buy Director bought 2,000,000 shares at an average $4.64 ($9,270,354)
  8. 4 Open-market buy SVP, Chief Medical Officer bought 10,000 shares at $4.58 ($45,800)
  9. 4 Open-market buy Director bought 10,000 shares at $5.00 ($50,000)
  10. 4 Grant or award President, R&D acquired 75,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 5 Insider Annual Insider Trading Report
  18. 5 Insider Annual Insider Trading Report
  19. 4 Option exercise Director acquired 114,250 shares (option exercise)
  20. 4 Grant or award Director acquired 58,140 shares (grant or award)

Page 19 of 29 · 564 filings